SAN MATEO, Calif., Jan. 18, 2017 -- Emergence Capital, a leading enterprise cloud venture firm is pleased to announce the promotions of Cathy Minshall to Chief Administration Officer and Donna derAshotian to Director of Finance. The promotions further strengthen Emergence Capital’s operations to assist in the firm’s mission of being the most important partner to the most important enterprise cloud companies.
"Cathy has been at the core of our firm as CFO for the last 6 years and has earned our trust and confidence,” said Gordon Ritter, General Partner at Emergence Capital. “We are excited to promote her to an even broader role of CAO so her talents can have even greater impact on how we run the firm each day. As part of Cathy’s increased responsibilities, we are promoting Donna to take on some of her former duties. Congratulations to this pair of leaders who will continue to shape the culture and performance at Emergence.”
Cathy joined Emergence Capital in 2011 as the Chief Financial Officer and has been responsible for finance, legal, human resources, information technology and facilities. Prior to joining Emergence, Cathy spent over 5 years as the CFO of De Novo Ventures, and served as the Controller for KPCB and the Mayfield Fund. She also has prior financial management experience with Ancora Capital, MGM and Westwood One. She began her career with PricewaterhouseCoopers in Los Angeles. Cathy holds a BS in Accounting from the University of the Pacific, is a Certified Public Accountant (inactive), has served on the Board of the West Coast Chapter of the Private Equity CFO Association (PECFOA) and is an active member of the National Venture Capital Association’s CFO Task Force.
Donna joined Emergence Capital in 2014. She has been working in the venture capital industry since 2000. Prior to joining Emergence, Donna worked at ONSET Ventures, and DeNovo Ventures as their Controller. Prior to that she worked at several venture firms including KPCB, Interwest, and 5AM Ventures. She started her career as an Assistant Controller / Controller in Real Estate, Property Management, and Construction. Donna graduated with a double major in Accounting and Design from University of San Francisco.
About Emergence Capital
Emergence Capital (@emergencecap), based in San Mateo, Calif., is the leading venture capital firm focused on early and growth-stage enterprise cloud companies. Its mission is to invest in cloud visionaries who are building the world's most important business applications. Emergence has over $900 million under management and is investing out of it's 4th institutional fund. The firm's investments include companies such as Salesforce.com (CRM), SuccessFactors (SFSF, acquired by SAP), Veeva Systems (VEEV), Yammer (acquired by Microsoft), ServiceMax (acquired by GE) and Box (BOX). More information on Emergence Capital can be found at http://www.emcap.com.
Contact Information Audrey Webb for Emergence Capital [email protected] 408-472-2603


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Apple Turns 50: From Garage Startup to AI Crossroads
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



